Table 1.
LAL/ | Analyte | Technique | Principle/Key Elements | Method | Sample | Reference |
---|---|---|---|---|---|---|
Non-LAL | ||||||
LAL | Endotoxin | Conventional/ Endotoxin-specific | Activation of pro-clotting enzyme in Limulus amebocyte lysate | Gel-clot | Plasma | Levin, J. [25] |
Chromogenic/Turbidimetric | Plasma | van Deventer, S.J. [15] Tamura, H. [16,17] Obayashi, T. [26] Inada, K. [28] Kambayashi, J. [33] |
||||
LAL alternatives (Endotoxin-specific) | Recombinant Factor C | Fluorogenic | Non-clinical | Ding, J.L. [41] | ||
Recombinant coagulation enzymes | Chromogenic | Pharmaceutical Non-clinical | Mizumura, T. [42] | |||
Modified LAL | Endotoxin scattering photometry (ESP) | Light scattering by small particles | Plasma | Shimizu, T. [35] | ||
Engineered firefly luciferases with improved sensitivity | Chromogenic | Dialysate | Noda, K. [36] | |||
Target LPS capture with LPS binding peptide produced by phage-display | Chromogenic | Pharmaceutical Non-clinical | Suzuki, M.M. [37] | |||
Target LPS capture with phage-derived protein | Chromogenic/ Fluorogenic | Pharmaceutical Non-clinical | Grallert, H. [38] | |||
Endosafe PTS device with a disposable cartridge | Chromogenic | Nuclear medicine, Pharmaceutical | Maule, J. [40] | |||
Electrochemical LAL assay | Chromogenic | Dialysate | Takano, S. [52] | |||
Non-LAL (Direct) | Endotoxin/ | GC/MS | β-hydroxymyristic acid content of Lipid A | Gas chromatograph-Mass spectrometer | Serum (Rabbit) | Maitra, S.K. [46] |
Lipid A | Immunological techniques | Antiserum to J5 mutant of E.coli 0111:B4 | ELISA | Milk | Mohammed, A.H. [48] | |
Endotoxin | Target LPS capture with polymyxin probe | ELISA | Non-clinical | Inoue, K.Y. [49] | ||
LPS O-antigen | Antiserum to O-polysaccharides | Radioimmuno-assay | Non-clinical | Munford, R.S. [50] | ||
Endotoxin | Fluorescence spectroscopy | Fluorescence-labelled Endotoxin Neutralizing Protein (ENP) | Fluorescence polarization | Non-clinical | Sloyer, J. [51] | |
Electro-chemistry-based | Electrochemical aptasensor | Signal amplification by enzymatic recycling | Non-clinical | Bai, L.J. [53] | ||
Non-LAL (Indirect, Cell-based) | Endotoxin | NF-κB | Monocyte activation test | Cytokines production | Pharmaceutical | Hoffman, S. [54] |
Pyrogen | MAT | Toll-like receptor 4/MD-2/CD14 | NFkB- reporter assay | Plasma (Rat) | Nishida, M. [56] | |
Endotoxin activity | EAA | Human neutrophil-complement opsonized LPS-IgM complexes | Chemilumi-nescent emission | Whole blood | Marshall, J.C. [58] | |
Relevant analytes | Anti-endotoxin antibody | Immunological techniques | Anti-bacteroides lipopolysaccharide IgG | Inhibition ELISA | Serum | Allan, E. [63] |
LBP | Endotoxin-LBP-sCD14 complexes | ELISA | Serum | Opal, S.M. [64] |